Member Info for rhubarbmk2

Bluecity; you are completely incorrect with that.

On the contrary, it has been explicitly stated that the multi-variance analysis conducted at PYC in no way precludes or delays a deal being done in the interim.

Nice try.

I used to be able to get an "upstairs, downstairs" (lolly stuck in the top of a double cone ice-cream), with hundreds and thousands, and strawberry sauce, for the price of a VAL share. It was a bargain at 20p.

There's an analogy in there I think.

Buy fresh, keep hold of the 6, and average down to a very achievable level. You'll feel better in the knowledge that charlatans no longer dilute this share like a bottle of vimto. Good luck, but you won't need it.

My honest take is that IAR still has his shares. I'd expect one-liner grenades thrown in, more periodically, from historic holders who can't move on. I also think he and I would agree in that the SP is going to go up - possibly substantially - at some stage, and I'll wager - in the not too distant future. And that's why he, and I suspect Valtree, are still holding.

Where I would differ is with patience. I've given feedback in the past when I thought improvements were needed, and I'd do it again. But when you call out the same repetitive diatribe, day after day, it loses all impact. I actually sat up when I read cobalts post earlier, and noted the number of "likes". Took that much more seriously, because cobalt isn't "at it" at it all the time.

I have two holdings in VAL. The first is old, the second, newer. On paper, the newer one is down, probably by about 60 grand. But I don't blame the board for that, because it's not down to mismanagement. Yes, it would be nice to hear more, but you do get fed up with "Kevin just went to the toilet and used Andrex" type of RNS feeds. I have a feeling we will all sit up at the next RNS. In fact, if I can get my act together, I think I'm going to buy a few more at this level.

I'm still incredibly relaxed about the board and the company. Two years to turn a biotech beast around, and I'd stick with that view.

I'm hoping off for a bit now, until we get a decent RNS to discuss, but what I would say is that we definitely don't have false prophets here, and many of the peers really do. Yes; Suzy is "nice", but, as I've said before, I don't think she suffers fools, and in pharma, these types are the ones that get on; some grit, but also someone who, if they say they'll deliver, does. I myself am still 100% still behind them, and I'm not the type to offer unconditional support easily.

If they're so bad, IAR, why don't you sell your shares?

If the SP ain't going to go up with this lot, which is evident to you, and the board are not going anywhere, anytime soon, which they're evidently not, why not have the courage of your convictions and ship out?

Fair question, no? Won't hold my breath for an answer, mind.

No idea - cut my own now, couldn't you tell on the podcast? :-)

Last time I went it was 25 quid in Alderley Edge. S*d that, rather have another 100 VAL shares.

Right; it's beer o'clock and I have some sheep and ducks to feed. Good luck old son :-)

OB - 2.36, and I'll personally send you a bottle of finasteride and a micro needler. You'll have a full bonce in no time, for when you drive over to Wales to woo Grace in your winnings-bought new Audi. Where is your old dear, btw?; it's been an effort to hang out with you reprobates waiting for her to post.

I did - I'm thinking 236p pal, and to see you buy yourself a lovely new comb, crafted from the finest silver :-)

Yes, but I didn't IAR.

Don't get me wrong. If by Dec 2021, everyone is still in the hole, I'll be the first to admit that you were right.

I've worked in this exact preclin-clinical transition space of pharma dev, for nearly 20 years, so at least I can say I did my research and went in with my eyes open.

But I will blame myself for bad choices, and not pass the buck.

Tell me you'll do the same if I'm right.

Sun's out today; it's beer o'clock in a few short hours, and I'm feeling bullish.

I reckon there's a good chance of 5/6 inflections before the year is out:

201 partnered or sold - hopefully first, and with a "window" of trading below cash as the market catches up. Strategy "confirmed"; Suzy vindicated. 90% probability (to me). 60% probability it eventually goes on to FDA approval, but we may have nothing to do with it by then.

401 is invested as a stand-alone, and progresses to an extended Phase 2b/3 in pancreatic adenocarcinoma. Patent as tight as a duck's ass. So this may be the exciting "underdog", that we all generally overlook to an extent, but it could be broadsheet news-worthy, if it works as expected. May retain 40-50% ownership. 80% probability.

301 is taken regionally by the Japanese, if they get their finger out before whoever takes 201 fancies having the whole patent series and global rights. 70% probability.

BC201 runs out of COVID "bandwidth", but BC find it pretty good in a model of acute influenza A, or similar, or frank sepsis, with a favourable interaction with TMPRSS2. 50% probability.

Suzy gets 2 more candidates in and her "Rottweiler" (whoever it is, and I mean that in the nicest possible way), spits one out, leaving one to be developed through 2022. 90% probability.

I went in on RedX a few years ago, as they had reached an all-time low, with virtual bankruptcy. They had one clinical candidate left with very attractive IP, and then the most poorly-written RNS landed (almost vindictive), saying that they'd "overdosed" their first patient. I convinced myself that they'd miscalculated the exposures and it could potentially be a very toxic drug on paper, so this seemed reasonable. MCap was really low - like VAL; SP was about 4-7p (wish I'd have put more in). Didn't sleep for weeks. MCap now about 200M and they still haven't finished their Phase 1. On paper, they have less clinically-proven data than VAL.

I'd like to say that VAL was my second "s**t or bust" investment. But we have excellent management here - truly noteworthy. So it has the excitement of a great investment, but, at least to me, without the worry. Sleep like a baby with it. There's no reason that the team cannot do an above about-turn with it, and I think they will.

The latest live QandA on the VAL website will bring you up to speed with just about everything Bonkers.

OK - I believe you pal.

To be fair, your computer is probably covered in so much froth and spit, that you wouldn't have been able to log on.

So - you've evidently watched the podcast, but you were playing golf and didn't watch it.

Which is it, Pinocchio?

Just trying to find out which of the larger companies only hold an acquisition board meeting every three months ;-)

Confidence remains unchanged. Strong buy.

201 is going into more patients; I'm certain of that.

Nothing.

One involves having balls.

No; I'm Spartacus!

If you'd got round to selling them, you wouldn't be here, Valtree.

Honestly; you and IAR should open a KFC franchise. It might be the one thing you both have expertise in.

Valtree - if I give you 1M shares if there's a placing after the AGM, and you give me your 1M shares if there isn't, do we have a deal old son?

Oh I love it pal; so much so, I treated myself to another 120K shares yesterday.